Healthcare and Medicine Reference
In-Depth Information
Lazarus, H.M., S.E. Haynesworth, S.L. Gerson, N.S. Rosenthal, and A.I. Caplan. 1995.
Ex vivo expansion and subsequent infusion of human bone marrow-derived
stromal progenitor cells (mesenchymal progenitor cells): implications for thera-
peutic use. Bone Marrow Transplant 16, no. 4: 557-64.
Lazarus, H.M., O.N. Koc, S.M. Devine, P. Curtin, R.T. Maziarz, H.K. Holland, E.J.
Shpall, P. Mccarthy, K. Atkinson, B.W. Cooper, S.L. Gerson, M.J. Laughlin, F.R.
Loberiza, Jr., A.B. Moseley, and A. Bacigalupo. 2005. Cotransplantation of HLA-
identical sibling culture-expanded mesenchymal stem cells and hematopoietic
stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 11,
no. 5: 389-98.
Le Blanc, K., I. Rasmusson, B. Sundberg, C. Gotherstrom, M. Hassan, M. Uzunel, and
O. Ringden. 2004. Treatment of severe acute graft-versus-host disease with third
party haploidentical mesenchymal stem cells. Lancet 363, no. 9419: 1439-41.
Le Blanc, K., L. Tammik, B. Sundberg, S.E. Haynesworth, and O. Ringden. 2003.
Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and
mitogenic responses independently of the major histocompatibility complex.
Scand J Immunol 57, no. 1: 11-20.
Luria, E.A., A.J. Friedenstein, J.F. Morris, and S.A. Kuznetzow. 1987. Bone formation
in organ cultures of bone marrow. Cell Tissue Res 248: 449-54.
Mackay, A.M., S.C. Beck, J.M. Murphy, F.P. Barry, C.O. Chichester, and M.F. Pittenger.
1998. Chondrogenic differentiation of cultured human mesenchymal stem cells
from marrow. Tissue Eng 4, no. 4: 415-28.
Majumdar, M.K., M.A. Thiede, J.D. Mosca, M. Moorman, and S.L. Gerson. 1998.
Phenotypic and functional comparison of cultures of marrow-derived mesen-
chymal stem cells (MSCs) and stromal cells. J Cell Physiol 176, no. 1: 57-66.
Meisel, R., A. Zibert, M. Laryea, U. Gobel, W. Daubener, and D. Dilloo. 2004. Human
bone marrow stromal cells inhibit allogeneic T-cell responses by indoleam-
ine 2,3-dioxygenase-mediated tryptophan degradation. Blood 103, no. 12:
Nasef, A., N. Mathieu, A. Chapel, J. Frick, S. Francois, C. Mazurier, A. Boutarfa, S.
Bouchet, N.C. Gorin, D. Thierry, and L. Fouillard. 2007. Immunosuppressive
effects of mesenchymal stem cells: Involvement of HLA-G. Transplantation 84,
no. 2: 231-7.
Ortiz, L.A., M. Dutreil, C. Fattman, A.C. Pandey, G. Torres, K. Go, and D.G. Phinney.
2007. Interleukin 1 receptor antagonist mediates the antiinflammatory and anti-
fibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci
USA 104, no. 26: 11002-7.
Otsuru, S., K. Tamai, T. Yamazaki, H. Yoshikawa, and Y. Kaneda. 2008. Circulating
bone marrow-derived osteoblast progenitor cells are recruited to the bone-
forming site by the CXCR4/stromal cell-derived factor-1 pathway. Stem Cells
26, no. 1: 223-34.
Owen, M. and A.J. Friedenstein. 1988. Stromal stem cells: marrow-derived osteogenic
precursors. CIBA Found Symp 136: 42-60.
Owen, M.E., J. Cave, and C.J. Joyner. 1987. Clonal analysis in vitro of osteogenic dif-
ferentiation of marrow cfu-f. J Cell Sci 87 (Pt 5): 731-8.
Penna, C., S. Raimondo, G. Ronchi, R. Rastaldo, D. Mancardi, S. Cappello, G. Losano,
S. Geuna, and P. Pagliaro. 2008. Early homing of adult mesenchymal stem cells in
normal and infarcted isolated beating hearts. J Cell Mol Med 12, no. 2: 507-21.
Search Pocayo ::

Custom Search